Lornoxicam is a non-steroidal anti-inflammatory drug of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and. Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory. Lornoxicam is a nonsteroidal anti-inflammatory drug with analgesic properties From: Profiles of Drug Substances, Excipients and Related Methodology,

Author: Tuzragore Tygor
Country: Chile
Language: English (Spanish)
Genre: Literature
Published (Last): 17 April 2004
Pages: 429
PDF File Size: 17.31 Mb
ePub File Size: 15.55 Mb
ISBN: 296-4-89095-813-9
Downloads: 80379
Price: Free* [*Free Regsitration Required]
Uploader: Nem

Cortivazol The risk or severity of gastrointestinal irritation can be increased when Cortivazol is combined with Lornoxicam.

What are the other precautions for Lornoxicam? Drugs A – Z.

Dexpropranolol Lornoxicam may decrease the antihypertensive activities of Dexpropranolol. Dapsone The metabolism of Lornoxicam can be increased when combined with Dapsone. Cephalexin Lornoxicam may decrease the excretion rate of Cephalexin which could result in a higher serum level. Indenolol Lornoxicam may decrease the antihypertensive activities of Indenolol.

Lornoxicam Drug Information – Indications, Dosage, Side Effects and Precautions

Dapoxetine The lodnoxicam or severity of gastrointestinal bleeding and gastrointestinal ulceration can be increased when Dapoxetine is combined with Lornoxicam. Chromic nitrate Lornoxicam may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.

Dapiprazole The risk or severity of hypertension can be increased when Dapiprazole is combined with Lornoxicam.

Macitentan The therapeutic efficacy of Macitentan can be decreased when used in combination with Lornoxicam. You can resubmit another bid.

  AKEBONO BRAKE PADS CATALOGUE PDF

Lornoxicam

Megestrol acetate Lornoxicam may decrease the excretion rate of Megestrol acetate which could result in a higher serum level. Ifosfamide Lornoxicam may decrease the excretion rate of Ifosfamide which could result in a higher serum level. Increased lornoxicam blood conc when given concomitantly with cimetidine. Clozapine Lornoxicam may decrease the excretion rate of Clozapine which could result in profilw higher serum level. Adrafinil The risk or severity of hypertension can be increased when Lornoxicam is combined with Adrafinil.

Lornoxicam and Lactation Contraindicated in lactation. Acrivastine Lornoxicam may decrease the excretion rate of Profilr which could result in a higher serum level.

Diphenhydramine The metabolism of Lornoxicam can be decreased when combined with Diphenhydramine. Flosulide Nimesulide ; Aminophenols anilines: Fosinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lornoxicam is combined with Fosinopril. Such insertions do not conform to our policy and ‘Terms of Use’ and are either deleted drgu edited and republished.

Cerivastatin The metabolism of Lornoxicam can be decreased when combined with Cerivastatin.

Lornoxicam – DrugBank

Meropenem Lornoxicam may decrease the excretion rate of Meropenem which could result in a higher serum level. Lansoprazole The metabolism of Lornoxicam can be increased when combined with Lansoprazole.

Ketorolac The risk or severity of adverse effects can be increased when Ketorolac is combined with Lornoxicam. Isoniazid Lornoxicam may decrease the excretion rate of Isoniazid which could result in a higher serum level.

  3M CP25WB PDF

Fluticasone The risk or severity lormoxicam gastrointestinal irritation can be increased when Fluticasone is combined with Lornoxicam. Lornoxicam and Pregnancy Contraindicated in crug.

Bosentan The therapeutic efficacy of Bosentan can be decreased when used in combination with Lornoxicam. Atropine The risk or severity of hypertension can be increased when Atropine is combined with Lornoxicam. Cyclothiazide The therapeutic efficacy of Cyclothiazide can be decreased when drkg in combination with Lornoxicam. Memantine Lornoxicam may decrease the excretion rate of Memantine which could result in a higher serum level.

Eperisone The risk or severity of hyperkalemia can be increased when Lornoxicam is combined with Eperisone. Alendronic acid The risk or severity of lornoxicm bleeding can be increased when Lornoxicam is combined with Alendronic acid. General Information on Lornoxicam. Fosaprepitant The metabolism of Lornoxicam can be increased when combined with Fosaprepitant. Cimicoxib The risk or severity of adverse effects can be increased when Lornoxicam is combined with Cimicoxib.

Bismuth Subsalicylate The therapeutic efficacy of Bismuth Subsalicylate can be decreased when used in combination with Lornoxicam. Fibrinolysin The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Fibrinolysin.